title: The potential role of nano- and micro-technology in the management of critical illnesses.
abstract: In recent years nanomedicine has become an attractive concept for the targeted delivery of therapeutic and diagnostic compounds to injured or inflamed organs. Nanoscale drug delivery systems have the ability to improve the pharmacokinetics and increase the biodistribution of therapeutic agents to target organs, thereby resulting in improved efficacy and reduced drug toxicity. These systems are exploited for therapeutic purposes to carry the drug in the body in a controlled manner from the site of administration to the therapeutic target. The mortality in many of the critical illnesses such as sepsis and acute respiratory distress syndrome continues to remain high despite of an increased understanding of the molecular pathogenesis of these diseases. Several promising targets that have been identified as potential therapies for these devastating diseases have been limited because of difficulty with delivery systems. In particular, delivery of peptides, proteins, and miRNAs to the lung is an ongoing challenge. Hence, it is an attractive strategy to test potential targets by employing nanotechnology. Here some of the novel nanomedicine approaches that have been proposed and studied in recent years to facilitate the delivery of therapeutic agents in the setting of critical illnesses such as acute respiratory distress syndrome, sepsis and ventilator associated pneumonia are reviewed.
authors.affiliation: Department of Veterans Affairs, Section of Pulmonary, Critical Care Medicine, Emory University, Atlanta, GA 30033, USA. Electronic address: ruxana.sadikot@emory.edu.
authors.forename: Ruxana T
authors.initials: RT
authors.lastname: Sadikot
mesh_terms: D016638:Critical Illness; D016503:Drug Delivery Systems; D006801:Humans; D055616:Microtechnology / Q000379:methods*; D050997:Nanomedicine / Q000379:methods; D036103:Nanotechnology / Q000379:methods*; D014018:Tissue Distribution
keywords: Critical illness; Lung injury; Nanomedicine; Pneumonia; Sepsis